Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects

Core Viewpoint - Broadwood Partners, L.P. and its affiliates are opposing Alcon Inc.'s proposed acquisition of STAAR Surgical Company, urging shareholders to vote against the transaction using their GREEN Proxy Card [1] Group 1: Company Actions - Broadwood Partners owns 27.5% of STAAR's outstanding common stock, indicating significant influence over shareholder decisions [1] - The firm continues to actively communicate its stance against the acquisition, highlighting its commitment to protecting shareholder interests [1] Group 2: Market Implications - The opposition from a major shareholder like Broadwood could impact the outcome of the acquisition vote, potentially leading to a reevaluation of the proposed transaction by Alcon [1]